P2Y12 inhibition after thrombotic thrombocytopenic purpura remission

Kahraman, Serkan; Ziyrek, Murat

Journal Metrics

Impact Factor (2022): 1.3
5-Year Impact Factor: 1.5
Eigenfactor Score: 0.00148
CiteScore (2022): 1.9
SCImago Journal Rank: 0.29

28/4Current Issue Ahead of Print Archive Most Accessed Articles

Quick Search

In authors and institutes
In titles and abstracts
In keywords
In all

pdf

P2Y12 inhibition after thrombotic thrombocytopenic purpura remission [Anatol J Cardiol]

Anatol J Cardiol. 2017; 17(5): 416-417 | DOI: 10.14744/AnatolJCardiol.2017.7772

P2Y12 inhibition after thrombotic thrombocytopenic purpura remission

Serkan Kahraman, Murat Ziyrek
Department of Cardiology, Silivri State Hospital; İstanbul-Turkey

Serkan Kahraman, Murat Ziyrek. P2Y12 inhibition after thrombotic thrombocytopenic purpura remission. Anatol J Cardiol. 2017; 17(5): 416-417

Corresponding Author: Serkan Kahraman, Türkiye
Manuscript Language: English

TOOLS Full Text PDF Print Download citation RIS EndNote BibTex Medlars Procite Reference Manager Share with email Share Send email to author Similar articles PubMed Google Scholar

Journal Metrics

Journal Citation Indicator: 0.18
CiteScore: 1.1
Source Normalized Impact
per Paper: 0.22
SCImago Journal Rank: 0.348

Quick Search

In authors and institutes
In titles and abstracts
In keywords
In all